Delivery Order SPE2DB22D1017-SPE2DB25FYSJQ
- Not listed
- The Defense Logistics Agency awarded a $2,619.84 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Teriparatide 560mcg/2.24mL pen injections, with an ultimate completion date of August 1, 2025. This firm fixed-price contract, awarded without set-aside designation through competitive procurement, is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $32,094.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,756.60 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on September 5, 2025, with completion targeted for September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will...
- The Defense Logistics Agency awarded a $3,468.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $26,852.75 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This contract represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used in...
- The Defense Logistics Agency awarded a $6,226.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injectors. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,422.77 to AmerisourceBergen Drug Corp for Teriparatide 560 MCG/2.24 ML pen injections on August 18, 2025, with a completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $4,076.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,676.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on June 6, 2025, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award represents a medical pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSJQDelivery Order
The Defense Logistics Agency awarded a $4,420.77 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 MCG/2.24 ML on September 29, 2025, with completion targeted for September 30, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Logistics Agency. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal healthcare customers. The Teriparatide procurement supports DLA's medical supply chain operations, enabling delivery of critical pharmaceutical products to defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/29/25 |